Supplementary
: Percentage of cell death in relation to normoxia for T24, 5637 and HT1376 under hypoxia, Dfx and Hypoxia in the presence of anti-STn monoclonal antibody TKH2. The results shows that growth in hypoxia, Dfx and exposure to the anti-STn antibody has minimum impact (> 5%) on cell viability, irrespectively of the cell line. Graphs represent average value of three independent experiments. *p < 0.05; **p < 0.01 (Student's T-test).
Supplementary Figure S4: (A)
Heat map comparing the expression of genes associated with stem cells (NANOG, LIN28A, POU5F1, KLF9, KLF4, SOX2) ; epithelial (CDH1, DSP, EPCAM); SNAI2, TWIST1, TWIST2, ZEB1, ZEB2, RUNX1, RUNX2, FN1) ; mesenchymal (CDH2, VIM, SPARC) phenotypes in T24, 5637 and HT1376 cell lines. T24 and 5637 evidence a more pronounced stem and mesenchymal character when compared to HT1376. Note the lower expression of epithelial markers (CDH1, DSP, EPCAM) in T24 and 5637 and higher expression of these markers in HT1376 cells. Moreover, T24 present a more marked stem cell character while 5637 showed a more mesenchymal phenotype. (B) Heat map showing alterations in gene expression for each cell line under hypoxia in relation to normoxia. Statistically significant down an upregulations for each cell line are pointed out. Accordingly, we observed a higher number of alterations in 5637 cell line, while HT1376 was mostly unchanged in hypoxia compared to normoxia in relation to the targeted genes. (C) Biological interpretation of gene transcription alteration in hypoxia using ClueGO and CluePedia for Cystoscape. T24 gene expression profiles highlighted a positive regulation of stem cell proliferation, reinforcing the stem cell character of these cells, accompanied by the negative regulation of cell adhesion under hypoxia, thus in agreement with the morphological analysis. In 5637 cells, deregulations in stem cell proliferation as well as the activation of the Wnt signalling pathway, which has been associated with invasive and metastatic potential of cells, were amongst the most relevant alterations. The few alterations presented by HT1376 cells under hypoxia did not allow this type of analysis. Altogether, these observations showed that T24 and 5637 bladder cancer cells, presenting a more pronounced stem and mesenchymal character, were more affected by hypoxia, endowing them with a more aggressive phenotype compared to HT1376, which showed a more marked epithelial nature. Figure S5 : Expression of the ST antigen in T24, 5637 and HT1376 cells in normoxia, hypoxia and exposure to Dfx. The ST antigen was determined after neuraminidase treament with the 3C9 monoclonal antibody against the T antigen, which is not expressed by these cell lines. Accordingly, hypoxia promotes a significant increase in ST expression in T24 and 5637 cell lines, but not in HT1376. Exposure to Dfx promotes an increase in this antigen in all cases, denoting a potential involvment of HIF-1α in ST regulation. Figure S6 : (A) Variations in ST6GALNAC1 transcription (average expression: 3 transcripts/10 6 reference genes) in hypoxia and Dfx compared to normoxia. ST6GALNAC1 transcription was increased in all cell lines and experimental conditions (hypoxia and Dfx) when compared to normoxia (upper graph). These observations were significantly more pronounced when considering all cell lines (lower graph). Data further suggests that ST6GALNAC1 transcription is regulated by HIF-1α. (B) Exemplificative western blot for T24 cell line showing equal amounts of ST6GalNAC-I in normoxia, hypoxia and Dfx. Given the low levels of ST6GALNAC1 transcripts, western blots were performed to confirm its presence. Accordingly, two main bands could be observed, below 75 kDa and near 50 kDa (blue arrows), corresponding to two different splice variants of this protein that have been described as fully functional. Similar results were obtained for the other two cell lines (data not shown). Based on these results, it was not possible to confirm the increase in ST6GalNAc-I suggested by RT-PCR. (C) Schematic representation of the initial steps of O-glycosylation, with emphasis on the mRNA overexpression of genes encoding glycosyltransferases (ST6GALNAC1, C1GALT1, GCNT1 and ST3GAL1) during hypoxia and Dfx treatments in relation to normoxia. Accordingly, we observed a trend increased in ST6GALNAC1 gene expression, encoding ST6GalNAc-I (responsible by the formation of the STn antigen; average expression: 3 transcripts/10 6 reference genes) in hypoxia and Dfx in relation to normoxia. These observations may, in part, account for the increase in STn expression in these conditions. In addition, we have observed a statistically significant increase in C1GALT1 transcription (average expression: 3 transcripts/10 2 reference genes) accompanied by a decrease in GCNT1 (average expression: 2 transcripts/10 2 reference gene) that encodes for C2GnT, responsible by further elongation in O-glycans. This was particularly notorious for T24 and 5637 cell lines (> 60%) in comparison to HT1376 (approximately 20%). Moreover, the significant overexpression of ST3GAL1 (average expression: 1 transcript/10 2 reference gene) may decisively contribute to an overexpression of the ST antigen. Altogether, these findings point towards an accumulation of short-chained sialylated O-glycans and inhibition of further O-glycan extension in hypoxia. Similar observations were made in cells exposed to Dfx treatment, suggesting that glycosyltransferase transcription is regulated by HIF-1α. Noteworthy, these events were observed in all cell lines, highlighting common responses regarding the transcriptional regulation of glycosyltransferases. These findings warrant deeper investigation in future studies. All graphs in this figure represent average value of three independent experiments, *p < 0.05; **p < 0.01; ***p < 0.001 (Student's T-test). Figure S7 : Schematic representation of the STn-expressing glycoproteins isolation and identification protocol. Briefly proteins were extracted from normoxic and hypoxic cells with 0.05% RapiGest, whose amphiphilic nature allows a good representation of membrane proteins, which commonly yield O-GalNac glycosylation (Step 1). The extracts were then treated with an α-neuraminidase, which removes the sialic acid from STn exposing the Tn antigen (Step 2). The extracts were then enriched for Tn-expressing glycoproteins by Vicia villosa agglutinin (VVA)-lectin affinity chromatography (Step 3) and eluted with 0.05% RapiGest at 100°C after extensive wash of unbound material (Step 4). The isolated glycoproteins were then reduced, alkylated and digested with trypsin (Step 5) and identified by nanoLC-ESI-MS/MS (Step 6). Since Tn antigen was not detected by flow cytometry and western blot in these cell lines we assume that its expression is negletabe and that the glycoproteins identified by this approach mainly correspond to STn-expressing glycoproteins.
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Supplementary Figure S8: Examples of annotated nanoLC-ESI-MS
2 Tn-glycopeptides spectra for (A) MUC16; (B) Integrin beta-2; (C) Protocadherin-23. A table presenting key ions for assigment of the peptide and glycosylation sites is presented bellow each spectrum.
Supplementary Figure S9: (A) Distribution of putative STn-expressing glycoproteins between the three cell lines in hypoxia.
The Venn diagram reinforces the notion that MUC16 is present in all cell lines in hypoxia. Interestingly, T24 and 5637 also shared the expression of integrin beta-1, which plays a critical role in cell adhesion and invasion and was previously described to be modified with the STn antigen [42] [43] [44] . (B) Expression of integrin beta-1 isolated by VVA lectin-affinity chromatography after neuraminidase treatment. Briefly, proteins isolated from T24, 5637 and HT1376 cells in normoxia and hypoxia were digested with α-neuraminidase, which removes the sialic acid from STn exposing the Tn antigen. The samples were then enriched for Tn-expressing glycoproteins by VVA affinity chromatography normalized in relation to the amount of used lectin. The glycoproteins were then separated by SDS-PAGE and blotted for integrin beta-1. Two bands could be observed (at approximately 100 and 150 kDa) in all cell lines and conditions, corresponding to the two main glycoforms of the protein. In agreement with this observation, integrin beta-1 has 13 putative O-glycosylation sites (according to NetOGlyc 4.0) and 12 putative N-glycosylations sites (according to NetNGlyc 1.0), that may account for these differences. Furthermore, these observations led to the conclusion that altered glycosylation is present in high as well as in low molecular weight integrin beta-1 glycoforms. Interestingly, western blot allowed the detection of integrin beta-1 in normoxia in all cell lines and in hypoxic HT1376, which were not identified by MS. The Figure also shows that hypoxia led to an overall increase in integrin beta-1 in T24 and 5637 cells, which would explain their identification by MS. Noteworthy, both cell lines presented a significant increase in low molecular weight integrin beta-1 glycoforms in hypoxia, which probably yields a higher number of short-chain O-glycans. Contrastingly, hypoxic HT1376 cells expressed significantly lower levels of both glycoforms in hypoxia when compared to normoxia. These observations support the notion that the STn antigen may be present in both low and high molecular weight integrin beta-1 glycoforms. Furthermore, it highlights that changes in the O-glycome accompanying hypoxia may result from both alterations in glycosylation pathways and the proteome. Future studies should devote to understanding the biological implications of these alterations. Figure S10 : Protein-Protein interactions given by STRING analysis for putative STn-expressing glycoproteins in hypoxia for (disconnected nods have been removed). Integrin beta-1 is a hub protein in terms of cell adhesion related interactions in both T24 and 5637 cell lines, further reinforcing the need for deeper investigations regarding its biological and clinical significance in bladder cancer. Importantly, the integration of HT1376 glycoproteins did not retrieve any functional relationships. 
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